TKT and neoplasm: 3D-quantification based on T2 MR imaging confirmed significant smaller tumor volumes (339.5+/-275 mm3) than in the controls that received no GCV after MSC-TK injection (2353+/-950 mm3) or that received no cells but GCV (1449+/-331 mm3).